Genetics of multiple myeloma
- 16 July 2005
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 18 (4) , 525-536
- https://doi.org/10.1016/j.beha.2005.01.006
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Clinical and biologic implications of recurrent genomic aberrations in myelomaBlood, 2003
- Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasiaCancer Science, 2003
- A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains anIGH/MMSET fusion transcriptBlood, 2003
- Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variantsBlood, 2003
- In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expressionBlood, 2003
- Multiple myeloma: evolving genetic events and host interactionsNature Reviews Cancer, 2002
- Multiple MyelomaCancer Genetics and Cytogenetics, 2000
- P53 deletion is not a frequent event in multiple myelomaBritish Journal of Haematology, 1999
- Hypodiploidy and 22q11 rearrangements at diagnosis are associated with poor prognosis in patients with multiple myelomaBritish Journal of Haematology, 1997
- MULTIPLE MYELOMA: ALMOST ALL PATIENTS ARE CYTOGENETICALLY ABNORMALBritish Journal of Haematology, 1996